activity
20192026
most citedAtlas: A Novel Pathology Foundation Model by Mayo Clinic, Charité, and Aignostics

4 citations · 4 across the 4 of their papers we have counts for

collaborators
Showing cs.CVShow all

5 papers · 1 filter

cs.CV2026

LUCAID: Agentic Multimodal AI for Lung Cancer Precision Pathology

Marie-Lisa Eich, Kai Standvoss, Timo Milbich +30

Lung cancer tissue diagnostics is complex, as therapy decisions in precision oncology rely on the integration of histomorphological, immunohistochemical, and molecular features. Ye…

cs.CV2026

Atlas H&E-TME: Scalable AI-Based Tissue Profiling at Expert Pathologist-Level Accuracy

Kai Standvoss, Miriam Hägele, Rosemarie Krupar +25

Hematoxylin and eosin (H&E) staining is the cornerstone of histopathology, yet scalable, quantitative analysis of H&E whole-slide images (WSIs) remains a central challenge in compu…

cs.CV2026

Atlas 2 -- Foundation models for clinical deployment

Maximilian Alber, Timo Milbich, Alexandra Carpen-Amarie +24

Pathology foundation models substantially advanced the possibilities in computational pathology --- yet tradeoffs in terms of performance, robustness, and computational requirement…

cs.CV20254 cited

Atlas: A Novel Pathology Foundation Model by Mayo Clinic, Charité, and Aignostics

Maximilian Alber, Stephan Tietz, Jonas Dippel +24

Recent advances in digital pathology have demonstrated the effectiveness of foundation models across diverse applications. In this report, we present Atlas, a novel vision foundati…

cs.CV2024

xCG: Explainable Cell Graphs for Survival Prediction in Non-Small Cell Lung Cancer

Marvin Sextro, Gabriel Dernbach, Kai Standvoss +5

Understanding how deep learning models predict oncology patient risk can provide critical insights into disease progression, support clinical decision-making, and pave the way for…